Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results

Multiple Sclerosis

Volumn 8, Issue 4, 2002, Pages 289-294

  Kaufman, Michael ^a   Gaydos, C A ^a   Sriram, S ^a   Boman, J ^a   Tondella, M L ^a   Norton, H J ^a  

^a MS Center   (United States)

Author keywords

Chlamydia pneumoniae; Multiple sclerosis; Polymerase chain reaction

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CEREBROSPINAL FLUID ANALYSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CULTURE TECHNIQUE; DISEASE EXACERBATION; FEMALE; GOOD LABORATORY PRACTICE; HUMAN; LABORATORY TEST; MALE; MULTIPLE SCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; ADOLESCENT; BACTERIAL INFECTION; CEREBROSPINAL FLUID; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY;

BACTERIAL DNA;

ADOLESCENT; ADULT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 0035996207     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms815oa     Document Type: Article

References (29)

1. Epidemiologic evidence for multiple sclerosis as an infection
2. Slow bacterial infections or autoimmunity
3. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS
4. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
5. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens
6. Immunogold-electron microscopic detection of Chlamydial boies in CSF sediment of multiple sclerosis patients
7. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids
8. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
9. Lack of detection of Chlamydia pneumoniae in cerebrospinal fluid from patients with multiple sclerosis
10. Lack of Chlamydia infection of the central nervous system in multiple sclerosis
11. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients
12. Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis
13. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
14. Multiple sclerosis and Chlamydia pneumonia
15. Chlamydia pneumoniae infections in patients with multiple sclerosis and related pathologies
16. Does Chlamydia pneumoniae play a role in the pathogenesis of multiple sclerosis?
17. Evidence for infection with Chlamydia pneumoniae in a subgroup of patient with multiple sclerosis
18. Association between Chlamydia pneumoniae infection and clinical activity in multiple sclerosis
19. Presence of Chlamydia pneumoniae DNA in cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis
20. Chlamydia pneumoniae in multiple sclerosis: Humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity markers
21. Chlamydia pneumoniae serology and risk of multiple sclerosis
22. Is Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis?
23. Chlamydia: A role for multiple sclerosis or more confusion?
24. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene
25. Touchdown enzyme time release-PCR for detection and identification of C. pneumoniae, C. trachomatis, and C. psittaci using the 16S rRNA and 16S-23S spacer rRNA genes
26. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
27. Development of a fluorescent probe-based PCR assay for detection of Chlamydia pneumoniae
28. Application of a nested, multiplex PCR to psittacosis outbreaks
29. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR